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Antibiotic functionalised polymers reduce
bacterial bioﬁlm and bioburden in a simulated
infection of the cornea†
Natalya Doroshenko,a Stephen Rimmer, b Richard Hoskins,b Prashant Garg,c
Thomas Swift, b Hannah L. M. Spencer,b Rianne M. Lord, b Maria Katsikogianni, b
David Pownall,b Sheila MacNeil, d C. W. Ian Douglasa and Joanna Shepherd *a
Microbial keratitis can arise from penetrating injuries to the cornea. Corneal trauma promotes bacterial
attachment and bioﬁlm growth, which decrease the eﬀectiveness of antimicrobials against microbial kera-
titis. Improved therapeutic eﬃcacy can be achieved by reducing microbial burden prior to antimicrobial
therapy. This paper assesses a highly-branched poly(N-isopropyl acrylamide) with vancomycin end
groups (HB-PNIPAM-van), for reducing bacterial attachment and bioﬁlm formation. The polymer lacked
antimicrobial activity against Staphylococcus aureus, but signiﬁcantly inhibited bioﬁlm formation (p =
0.0008) on plastic. Furthermore, pre-incubation of S. aureus cells with HB-PNIPAM-van reduced cell
attachment by 50% and application of HB-PNIPAM-van to infected ex vivo rabbit corneas caused a 1-log
reduction in bacterial recovery, compared to controls (p = 0.002). In conclusion, HB-PNIPAM-van may
be a useful adjunct to antimicrobial therapy in the treatment of corneal infections.
Introduction
Biofilm formation is central to the colonisation of materials
and tissues by infective bacteria.1 The adhesion of bacterial
cells to surfaces (whether biotic or abiotic) is the initial stage
of formation of biofilms,2 which are bacterial communities
attached to a surface encased in a biopolymer matrix.3 It is
estimated that 80% of all clinical infections are biofilm
related4 and the particular clinical problem they pose is their
high levels of antimicrobial non-responsiveness compared
with planktonic bacteria. This non-responsiveness is not gen-
erally due to acquisition of resistance genes but instead arises
from altered physiological and physical features of the commu-
nity.5,6 The biomolecule-enriched matrix provides a pene-
tration barrier to antimicrobials7 and subpopulations of
bacteria in biofilms (known as persister cells) grow more
slowly and are less metabolically active than their planktonic
counterparts.5 Thus biofilm infections are diﬃcult to treat and
therefore strategies that prevent biofilm formation or disrupt
established biofilms may oﬀer valuable adjuncts to anti-
microbial therapy.8–10 Biofilm disruption can be achieved by
applying complexing agents or surfactant molecules,11–13 such
as low molar mass14 or polymer amphiphilles.15,16
Antimicrobial peptides and lipopeptides are also amphiphiles
and they are known to disrupt biofilms.17,18
In previous work we showed that highly-branched poly(N-
isopropyl acrylamide) (HB-PNIPAM) functionalised at the
chain ends with vancomycin (HB-PNIPAM-van) responded
after binding to bacteria by desolvation of a fraction of the
polymer segments.19–22 Upon attachment of bacteria to the
vancomycin chain ends, the polymer passes through a phase
transition that involves desolvation of segments. This induces
a change in the conformation of the polymer from a coiled to
a globular state (Fig. 1), which in this context manifests macro-
scopically as the formation of polymer–bacteria aggregates.
Similarly, results were reported with a polymyxin variant of the
same polymers (HB-PNIPAM-pmx) on binding to the Gram
negative species, Pseudomonas aeruginosa.23 Although often
described as a hydrophobic phase, the globular desolvated
state is amphiphilic and retains water after the main desolva-
tion event. In this context, we considered that bacteria being
bound within the desolvated polymer structures would disrupt
biofilms in the same way that other amphiphiles have been
shown to act. However, the disruptive action would be
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expected to be enhanced as the polymer competes with the
extracellular macromolecules of the biofilm to bind to the resi-
dent bacteria. In support of this concept, previous work by us
has also shown that both HB-PNIPAM-van and HB-PNIPAM-
pmx can dislodge bacteria from in vitro infected dermal tissue
models.20
As an exemplar of this principle we examined the eﬀect of
the HB-PNIPAM-van polymer on biofilms associated with
infection of the eye, microbial keratitis. Microbial keratitis is a
sight-threatening disease, and is recognized by the World
Health Organization as a major cause of corneal-related blind-
ness.24 The disease can have a bacterial, fungal, viral or proto-
zoal cause and the most common bacteria are Staphylococcus
aureus and Pseudomonas aeruginosa,25 although streptococcal
and enterobacterial causes are also known. Since ophthalmic
biofilm infections, also implicated in cases of endophthalmitis
and crystalline keratopathy,26 are so diﬃcult to treat, surgical
removal of the infected tissue resulting in corneal blindness
often remains the only permanent treatment option.27
In this work, we evaluate the eﬀect of HB-PNIPAM-van on
the ability of S. aureus to attach and form a biofilm on a
plastic substrate and its ability to remove bacteria form a simu-
lated infection model of keratitis using ex vivo rabbit corneas.
Results and discussion
HB-PNIPAM-van binds S. aureus but not P. aeruginosa
A HB-PNIPAM-van polymer was prepared. The material had a
degree of branching of 0.042, Mn 1937 kDa, Mw = 2269 kDa,
and the chain end functionality was 0.08 mg vanc per mg
polymer, (see ESI† for full details). HB-PNIPAM-van has been
previously shown to interact with S. aureus using an “aggrega-
tion assay” that showed the formation of large bacterial
aggregates in the presence of HB-PNIPAM-van.19,20 In the work
reported here, electron microscopy was used to investigate the
polymer–bacteria interaction. Fig. 2a shows an image of
S. aureus alone dispersed evenly on a surface. Incubation of
Fig. 1 Diagram showing the interaction of HB-PNIPAM-van with Gram-
positive bacteria. (a) Chain-end groups bind to bacteria, causing the
outer segments in HB-PNIPAM-van to desolvate (shown in black), pro-
viding an interface that promotes adhesion of bacteria more eﬀectively
than the solvated state. (b) Solvated state of HB-PNIPAM-van (shown in
blue) does not promote bacterial binding.
Fig. 2 Incubation of S. aureus with HB-PNIPAM-van results in formation of aggregates. (a) Electron micrographs showing the formation of S. aureus
and HB-PNIPAM-van aggregates. Scale bar, 20 µm. More images of polymer–bacteria aggregates can be seen in ESI, Fig. S5 and S6.† (b) The average
number of viable S. aureus and P. aeruginosa cells attached to HB-PNIPAM-van-treated or PBS-treated (control) microplate wells. Error bars; stan-
dard error of the mean, n = 9 (3 independent experiments, 3 replicates for each experiment).
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HB-PNIPAM-van with S. aureus for 4 hours resulted in the for-
mation of large bacterial aggregates with average dimensions
of 13 µm. Further images of aggregates formed by
HB-PNIPAM-van only and HB-PNIPAM-van with S. aureus over
shorter timescales can be seen in ESI, Fig. S5 and S6.†
To quantify the degree of polymer–bacteria interaction,
viable counts of attached bacteria in wells to which
HB-PNIPAM-van was anchored to the surface via an anti-vanco-
mycin antibody were determined. For comparison attachment
of a Gram-negative species, P. aeruginosa, which should not
bind significantly to HB-PNIPAM-van, was assessed. The value
for S. aureus attachment to the control wells (anti-vancomycin
but no polymer) was higher than expected but this was prob-
ably due to protein A-mediated binding to the mouse IgM.
Nonetheless, viable count data showed a significant, 60% rise
in S. aureus cell attachment (p = 0.0038) to polymer-coated
wells as opposed to the uncoated control (PBS) (Fig. 2b).
Moreover, there was no significant diﬀerence in the attach-
ment of P. aeruginosa to PBS or HB-PNIPAM-van treated sur-
faces, confirming earlier findings that HB-PNIPAM-van exhi-
bits binding specificity for S. aureus.20
HB-PNIPAM-van inhibits cell attachment and biofilm formation
To determine the eﬀect of HB-PNIPAM-van on S. aureus
biofilm formation, total biofilm biomass of 24 h biofilms
formed in the presence of HB-PNIPAM-van was measured
using crystal violet staining. HB-PNIPAM-van caused a 38%
and 61% reduction in biofilm biomass formed by S. aureus
S-235 and S. aureus NCTC 8325-4 respectively, when compared
to the PBS control (Fig. 3). It is important to highlight that the
concentration of HB-PNIPAM-van used in this assay was 10
times lower (0.5 mg ml−1) than in the other experiments pre-
sented in this paper but was still suﬃcient to cause a statisti-
cally significant inhibition of biofilm formation for S. aureus
S-235 (p = 0.0008) and S. aureus NCTC 8325-4 (p = 0.001).
Interestingly, HB-PNIPAM-van caused a larger reduction in the
biofilm biomass of S. aureus NCTC 8325-4, which was the
better biofilm-forming strain.
To determine how HB-PNIPAM-van interferes with biofilm
formation, Syto9-stained S. aureus S-235 was pre-incubated
with HB-PNIPAM-van and added to a microplate to initiate
attachment. The results showed that a much lower proportion
of S. aureus attached to the micro-plate when the bacteria were
pre-treated with HB-PNIPAM-van as opposed to treatment with
PBS (Fig. 4a). Furthermore, the micrographs were confirmed
by quantification of fluorescence intensity of attached bacteria,
which showed that polymer pre-treated cells attached at a stat-
istically significantly lower level than untreated cells (p =
<0.001) (Fig. 4b). A similar experiment in which the fluo-
rescence intensity of diﬀerent concentrations of S. aureus (cells
per ml) was measured (ESI, Fig. S7†) revealed that 109 cells per
ml resulted in a fluorescence intensity reading of 43 687 RFU.
The diﬀerence in fluorescence intensity from the bacterial
cells treated with PBS or HB-PNIPAM-van treated surfaces was
12 583 RFU (Fig. 4b). This suggests that HB-PNIPAM-van inhib-
ited the attachment of approximately 3 × 108 cells per ml.
HB-PNIPAM-van changes biofilm architecture
To assess the eﬀects of HB-PNIPAM-van on pre-formed bio-
films, the total number of bacteria left after treatment with
HB-PNIPAM-van and their metabolic activity was quantified
from biofilms treated with PBS or HB-PNIPAM-van for
24 hours. The results showed no significant diﬀerences in the
Fig. 3 HB-PNIPAM-van inhibits S. aureus bioﬁlm formation. Total
bioﬁlm biomass measured by absorbance of crystal violet of 24 h
S. aureus, S235 and S. aureus NCTC 8325-4 bioﬁlms, grown in micro-
plate wells in BHI or BHI supplemented with 500 µg ml−1 of
HB-PNIPAM-van. Error bars; standard error of the mean, n = 18 (3 inde-
pendent experiments, 6 replicates for each experiment).
Fig. 4 HB-PNIPAM-van inhibits S. aureus attachment. (a) Fluorescence
microscopy images of S. aureus cells stained with Syto-9 attached
to microplate wells following a 4 h, pre-incubation period with
HB-PNIPAM-van or PBS (control). Images are representative of data
from 3 independent experiments. (b) Fluorescence intensity of S. aureus
cells attached to microplate wells following a 4 h, pre-incubation
period with HB-PNIPAM-van or PBS (control). Error bars; error of the
mean, n = 18 (3 independent experiments, 6 replicates for each
experiment).
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number of recovered viable bacteria from biofilms treated with
PBS (2.7 × 108 (±6.7 × 107) CFU ml−1) or HB-PNIPAM-van (2.8 ×
108 (±3.9 × 107) CFU ml−1) (Fig. 5a), indicating that
HB-PNIPAM-van did not kill bacteria in this system. Similarly,
there was no diﬀerence in the metabolic activity of bacteria
between the PBS and HB-PNIPAM-van treated biofilms
(Fig. 5b) suggesting that HB-PNIPAM-van has no aﬀect on pro-
liferation of bacteria within biofilms. However when PBS and
polymer-treated biofilms were analysed by microscopy, diﬀer-
ences in the structure of the biofilm were observed (Fig. 6).
Phase contrast microscopy showed that compared to biofilms
exposed to HB-PNIPAM-van, PBS-treated biofilms were formed
of larger aggregates (Fig. 6a). Similarly, SEM data revealed that
control biofilms contained fewer but larger aggregates than
the polymer-treated biofilm (Fig. 6b). High magnification
images of the aggregates observed in both biofilm samples
also showed that control biofilms consisted of much larger
aggregates (Fig. 6c). Since the bacterial population between
PBS-treated and polymer-treated biofilms is similar (Fig. 5a), it
is possible that bacteria residing in control biofilms produce a
greater abundance of biofilm matrix molecules which form the
basis of the larger aggregates observed in control biofilms.
Given that HB-PNIPAM-van binds bacteria, the findings pre-
sented in Fig. 6c, suggest that the polymer may have prevented
S. aureus cells from either being integrated into the already
formed aggregates or from actively forming their own aggre-
gates, and so HB-PNIPAM-van may promote the segregation of
S. aureus as individual cells (Fig. 6c).
Data from fluorescence experiments, in which PBS and
polymer-treated biofilms were stained with the fluorescently
labelled lectin (WGA), showed that polymer-treated biofilms
appeared thinner and more dispersed compared to control
biofilms, which developed as a thick collection of conjoined
aggregates (Fig. 6d). Since poly-N-acetylglucoasmine (PNAG) is
an abundant component of S. aureus biofilms and WGA binds
to N-acetylglucosamine residues within bacteria and the
biofilm matrix, the data suggest that the abundance of PNAG
was reduced in the biofilm exposed to HB-PNIPAM-van, given
the absence of larger areas of WGA fluorescence (Fig. 6d).
Collectively these findings imply that HB-PNIPAM-van alters
the biofilm structure and possibly the arrangement of bacteria
within the biofilm.
Fig. 5 HB-PNIPAM-van does not aﬀect bioﬁlm bacterial growth. (a) The
number of bacterial cells recovered from 24 h bioﬁlms of S. aureus fol-
lowing 24 h treatment with PBS or HB-PNIPAM-van (5 mg ml−1). Error
bars; standard error of the mean, n = 9 (3 independent experiments, 3
replicate bioﬁlms for each experiment). (b) Absorbance of XTT solution
converted by metabolically active bacterial cells from PBS and
HB-PNIPAM-van treated S. aureus bioﬁlms. Error bars; standard error of
the mean, n = 15 (3 independent experiments, 5 replicate bioﬁlms for
each experiment).
Fig. 6 HB-PNIPAM-van changes bioﬁlm structure. Representative
microscopy images of S. aureus 24 h bioﬁlms following treatment with
PBS (control) or HB-PNIPAM-van for 24 hours; (a) phase contrast-
microscopic images of control and HB-PNIPAM-van-treated bioﬁlms, (b)
low magniﬁcation electron microscopic image of similar samples
stained with alcian blue and osmium tetroxide. (c) High magniﬁcation
electron microscopic images of samples in (b). (d) Fluorescence micro-
scopic images of treated and untreated bioﬁlms stained with Texas Red
wheat germ agglutinin (WGA). White arrows indicate aggregates.
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HB-PNIPAM-van reduces the bioburden in a corneal infection
model
To test the potential of HB-PNIPAM-van as a treatment for
tissue infections, HB-PNIPAM-van or PBS (control treatment)
were applied to deliberately wounded and infected ex vivo
rabbit corneas for a period of 4 hours. Afterwards the corneas
were washed and the remaining bacteria enumerated. The data
showed that corneas exposed to HB-PNIPAM-van contained
significantly fewer (p < 0.002) bacteria than corneas treated
with PBS (Fig. 7a). Since the application of HB-PNIPAM-van to
infected corneas resulted in a 10-fold reduction in concen-
tration (CFU ml−1) of bacteria, this demonstrates that
HB-PNIPAM-van eﬀectively reduces the bioburden in a corneal
infection.
In a similar experiment, PBS and polymer-treated corneas
were examined by microscopy, specifically focusing on the
area around the wound made to the cornea during the infec-
tion process, as this was the area of the cornea previously
shown to harbour the most bacteria.28 As seen in Fig. 7b & c,
in the PBS-treated cornea, GFP-labelled S. aureus formed large
aggregates not only in the location of the wound, but through-
out the entire cornea. Alternatively, the cornea exposed to
HB-PNIPAM-van treatment appeared to contain much fewer
S. aureus aggregates and these appeared smaller in size and
were mostly localised around the surface of the scratch wound
(Fig. 7b & c). Some green background autofluorescence from
the corneal cells is also visible.
To address any potential cytotoxicity issues, all polymeric
materials were found to be non-toxic to human epithelial (and
other tested) cell types following 3-(4,5-dimethylthiazol-2-yl)-
2,5-diphenyltetrazolium Bromide (MTT) cell viability tests (see
ESI, Table S3†).
Discussion
The aim of this study was to explore the potential of
HB-PNIPAM-van to influence biofilm formation and already
formed biofilms both on abiotic surfaces and in an infected
tissue model. This study builds on the work of Shepherd et al.
(2011),20 which showed that HB-PNIPAM-van could bind but
not kill bacteria in an infected skin wound model and shows
the generality of the approach. The findings presented here
provide more information on how the HB-PNIPAM-van inter-
acts with S. aureus and how the polymer aﬀects the formation
and development of S. aureus biofilms.
The current work shows that HB-PNIPAM-van exhibited
activity against S. aureus but not P. aeruginosa (Fig. 2b), which
is consistent with the binding mechanism of vancomycin; the
Gram-negative outer membrane provides a penetration barrier
to large molecules like vancomycin29 and HB-PNIPAM-van, so
preventing binding to the vancomycin target. Furthermore,
eﬀective binding between HB-PNIPAM-van and S. aureus (an
interaction which caused a significant reduction in bacterial
numbers in infected cornea, Fig. 7) occurred within a relatively
short time frame (4 hours), suggesting that HB-PNIPAM-van
could be a viable candidate for topical application. Using a
tissue-engineered human skin model of a burn wound, it was
previously shown that treatment with HB-PNIPAM-van for
1 hour caused a significant reduction of the bacterial biobur-
den in the wound,20 thus further demonstrating the versatility
of this polymer. Biofilm formation of S. aureus in nutrient rich
media was inhibited in the presence of HB-PNIPAM-van
(Fig. 3) and pre-incubation of S. aureus cells with HB-PNIPAM-
van inhibited their attachment to an abiotic surface (Fig. 4).
Many bacteria live on surfaces as biofilms; contact lens-associ-
ated microbial keratitis is characterized by biofilm growth on
the lens, whereas in endophthalmitis, staphylococci adhere to
intraocular lenses leading to infection of the intraocular
cavity.26 Treatment with HB-PNIPAM-van may be of benefit in
such cases as the anti-fouling properties of HB-PNIPAM-van
may prevent the bacteria on the implant from spreading,
Fig. 7 HB-PNIPAM-van reduces bacterial load in a corneal infection
model. (a) The number of S. aureus cells recovered from S. aureus
infected ex vivo rabbit corneas following a 4 h treatment with
HB-PNIPAM-van or PBS (control). Error bars; standard error of the
mean, n = 9 (3 independent experiments, 3 replicate corneas per an
experiment). (b) Photograph of an ex vivo rabbit cornea which has been
scratched with several criss-cross lines using a scalpel. Scratches are
illustrated in the photograph with black solid lines. The box drawn in
black dashed lines represents areas of interest which formed the basis of
confocal microscopy analysis; i.e. the scratch sites were predicted to
harbour most bacteria and so confocal images of these particular sites
of the cornea were taken. (c) Representative confocal microscopy
images of infected ex vivo rabbit corneas following a 4 h treatment with
HB-PNIPAM-van or PBS (control). White dashed outline illustrates the
shape of the scratch made during the infection stage of the experiment.
Background ﬂuorescence is auto-ﬂuorescence from the cornea. White
arrows indicate bright circular aggregates of GFP-labelled S. aureus,
which are conﬁned to the scratch area. Raw confocal microscopy
images can be seen in ESI, Fig. S4.†
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attaching and colonizing the cornea and thus HB-PNIPAM-van
may retard the development of implant associated corneal
infections. However, this requires further exploration.
Important findings from this study show that HB-PNIPAM-
van is able to reduce the binding of bacteria to surfaces and
alter the structure of the remaining biofilm (Fig. 6) in an estab-
lished corneal infection (Fig. 7) Compared to a biofilm treated
with PBS, HB-PNIPAM-van treated biofilms consisted of
smaller bacterial aggregates and a more dispersed biofilm
matrix showed that HB-PNIPAM-van is able to bind bacteria
from an established corneal infection (Fig. 7), and that it
altered the structure of the remaining biofilm (Fig. 6).
Compared to a biofilm treated with PBS, HB-PNIPAM-van
treated biofilms consisted of smaller bacterial aggregates.
Such modified biofilm structures may allow greater pene-
tration of antimicrobials into the depths of the biofilm and
achieve greater killing. Collectively these data suggest that
HB-PNIPAM-van could be given as an adjunctive topical treat-
ment alongside antimicrobials. In an established corneal
infection, HB-PNIPAM-van could eliminate enough bacteria
from the site of injury and subsequently reduce the overload
on the eye’s natural defence systems. The dispersion of the
biofilm matrix created by the polymer and the lower bacterial
concentration in the eye following polymer treatment could
improve the success rate of subsequent antimicrobial therapy,
using pre-existing agents such as Moxifloxacin.
Whilst it is clear that the eﬀects of polymers and other
materials on biofilms is complex, time dependent and species
dependent, the data support the hypothesis that HB-PNIPAM
with selective ligands at the chain ends forms specific aggre-
gates with the target bacteria, and that these aggregates
disrupt the normal formation of biofilms. The aggregates are
large amphiphilic structures and their formation appears in
this case to promote the dispersion of the biofilm as the
bacteria preferentially attach to the polymer rather than the
extracellular macromolecules of the biofilm or the underlying
surface.
Experimental
Materials
N-Isopropylacrylamide, NIPAM (97%), N-hydroxysuccinimide,
NHS (98%), dicyclohexyl carbodiimide, DCC (98% purity), azo-
biscyanovaleric acid, ACVA (98%), and vancomycin hydro-
chloride hydrate were obtained from Sigma Aldrich.
4-Vinylbenzylpyrrole carbodithioate (1) was synthesised and
purified according to the previously reported method.30
Dioxane (Analar grade), diethyl ether (anhydrous), dimethyl
formamide (Analar grade), ethanol (Analar grade), acetone
(Analar grade) and hydrochloric acid (35% wt/wt) were
obtained from VWR Ltd.
Highly-branched polymer (HB-PNIPAM)
NIPAM (20 g, 0.17 moles), 1 (1.84 g, 0.0071 moles) and ACVA
(1.98 g, 0.0071 moles) were dissolved in 140 ml of 1,4-dioxane.
The solution was degassed and the polymerization conducted
under nitrogen at 60 °C for 48 hours. The polymers were puri-
fied by precipitation (twice) in diethyl ether. Sample yield
23.1 g, monomer conversion = 97%. The polymer was then dis-
solved in ethanol and the lower molar mass fraction was
removed using ultra-filtration through a 10 000 g mol−1 molar
mass cut oﬀ membrane. 1H NMR (400 MHz, DMSO) (ppm): d
0.9–1.1 (6H, s, –N(CH3)2), d 1.3–1.7 (2H, br m, –CH2–CH–Ar–),
d 1.8–2.2 (2H, br m, –CH2–CH–CO–NH–) and (1H, br m, CH2–
CH–CONH–), d 3.3 (H2O-polymer bound), d 3.9 (1H, br s,
(CH3)2CH–), d 6.4 (H2, br s, N-pyrrole–H), d 6.6–7.6 (br m,
–Ar–), d 7.7 (2H, br s, N-pyrrole–H), d 12.2 (br m COOH). FTIR
peak from COOH at 1713 cm−1. The polymer molar mass
moments after ultra-filtration via methanol size exclusion
chromatography were Mn 1937.2 kDa, Mw 2269.9 kDa, Mz
2698.2 kDa, LCST (deionised H2O) 18.6 °C.
Polymer chain end modification
The chain ends of the highly branched polymers were con-
verted to carboxylic acid by means of 3 additions of ACVA (20
fold molar excess relative to RAFT agent in the initial poly-
merisation feed). HB-PNIPAM (22 g) was dissolved in DMF
(150 ml). ACVA (19 g, 0.068 moles) was added 3 times after
24 hours intervals. The solution was maintained at 65 °C
under a nitrogen atmosphere. The polymer was precipitated
into diethyl ether. The solid was dissolved in ethanol and con-
centrated by ultra-filtration and then rotary evaporated to
remove the solvent. 17.7 g of derivatised polymer was
obtained. FTIR COOH 1713 cm−1. LCST 19.3 cm−1. The car-
boxylic acid groups were converted to succinimide by reaction
of carboxylic acid chain ends with N-hydroxysuccinimide.
Highly branched polymer with carboxylic acid chain ends
(17.7 g) was dissolved in DMF (150 ml). N-Hydroxy succinimide
(3.03 g, 0.027 moles) and dicyclohexyl carbodiimide (5.5 g,
0.027 moles) were added and the solution stirred overnight.
The mixture was filtered and the polymer precipitated into
diethyl ether. The solid was dissolved in ethanol and concen-
trated by ultra-filtration (10 000 g mol−1 molar mass cut oﬀ
membrane) and then rotary evaporated to give 11.8 g of
polymer, 67% yield. FTIR (succinimide) 1741 cm−1, 1783 cm−1.
LCST 19.7 °C. Succinimide derivatized polymer (3 g) was dis-
solved in water (150 ml) over ice. A solution of vancomycin
(144 mg, 9.7 × 10−5 moles) in phosphate buﬀered saline pH
9.5 (5 ml) was added. The solution was stirred for 3 days at
room temperature and purified by ultrafiltration and then
freeze dried. FTIR (ESI, Table S1†) shows no identified succini-
mide or COOH peaks. Mn 4402 kDa, Mw 5439 kDa, Mz
6380.6 kDa, RH (DOSY, D2O) Rhn 8.22, Rhw 8.24, Rhz 8.26 nm.
LCST (deionised H2O) 32.5 °C.
Polymer characterisation
All 1H NMR spectra (ESI, Table S2†) were measured and
recorded on a Bruker AC400 which was operated at with D2O
as the solvent. FTIR measurements were carried out on a
Thermo Scientific Nicolet iS10 FTIR Spectrometer. Solid
samples were dried in a vacuum oven overnight before use.
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Polymer molar mass averages were obtained by size exclusion
chromatography using Agilent Polargel columns with metha-
nol as the eluent, using previously published methodologies.31
This used 3× Agilent Polargel columns connected to an Agilent
1260 Infinity system with a refractive index, ultraviolet light
and viscometric detector, and was calibrated using linear
polyNIPAM standards with a methanol eluent at 1 ml min−1
flow rate. Polymer hydrodynamic radii (RH) were calculated
using diﬀusion ordered spectroscopy (DOSY) NMR in D2O at
298 K. Diﬀerential Scanning Calorimetry (DSC) was carried out
using a TA Instruments MicroDSC in deionised water (1 mg
ml−1) polymer solution in the range 2 to 60 °C at heating rate
of 1 °C min−1. Raw data (NMR, FTIR, GPC) are contained in
the supplementary material (Fig. S1–S3, Tables S1 and S2†).
Polymer samples were stored as a dry powder at −18 °C.
Bacterial culture
Four strains of S. aureus were employed; a reference strain
NCTC 8325-4, strain NCTC 6571, strain SH1000-GFP (provided
by the Foster lab, University of Sheﬃeld) and strain S-235, a
local clinical isolate. In addition P. aeruginosa strain SOM-1, a
local clinical isolate was used. All strains were cultured in
brain heart infusion (BHI) broth (Oxoid, UK) at 37 °C overnight
and stored at 4 °C on BHI agar (Sigma-Aldrich, UK). The
number of bacterial cells in an overnight culture was enumer-
ated by microscopic counting and diluted to the concen-
trations required for each experiment.
Electron microscopy analysis of HB-PNIPAM-van and bacteria
binding
Overnight bacterial cultures of S. aureus S-235 were diluted
with H2O to concentrations of 1 × 10
8 CFU ml−1. Afterwards,
10 μl of each sample was pipetted on to a cylindrical glass
slide and left to stand for 2 hours at room temperature to
facilitate attachment. If required, 100 µl of 0.5 mg ml−1
polymer solution was added to the bacterial sample and left to
stand for 4 hours at room temperature before aspiration.
Bacteria were fixed using 2.5% glutaraldehyde (GA) (Sigma
Aldrich, Cat no. G5882) for 20 minutes. Following aspiration of
the GA, samples were washed twice with 100 μl of H2O and
then dehydrated via a graded 100 μl ethanol series (10, 30, 50,
70, 90, 100% ethanol, 10 minutes each) before re-aspiration.
Samples were then sputter coated in gold (4 nm) under a
10 mA current for 1 minute and imaged under low vacuum
(pressure of 0.59–0.63 Torr) using a scanning electron micro-
scope (Quanta 400 FEI).
Quantification of bacteria binding to HB-PNIPAM-van
Monoclonal mouse anti-vancomycin antibody (M997129;
Abcam, UK) (100 µl per well) was diluted in coating buﬀer
(sodium bicarbonate, 0.035 M, sodium carbonate, 0.015 M
and sodium azide, 0.003 M, adjusted to pH 9.6) at a ratio of
1 : 500 in 96-well ELISA microplates and incubated at 4 °C over-
night. The plates were then washed 4 times with 200 µl
PBS-Tween (1 µl Tween 20 per 200 ml of PBS) and HB-PNIPAM-
van (5 mg ml−1 in PBS) was added to some wells while PBS was
added to others to act as a control. The plates were incubated at
RT overnight, washed 4 times with 200 µl of PBS and 100 µl per
well of bacterial suspension was added and incubated at room
temperature (RT) overnight. S. aureus S-235 or P. aeruginosa
suspensions were prepared at 7 × 108 cells per ml in PBS.
After removal of any unattached bacteria by washing 4
times in PBS, attached bacteria were dislodged by thoroughly
scraping and vigorously pipetting 100 µl of PBS in each well.
Serial dilutions were then made and viable counting per-
formed following spotting (10 μl) of each dilution onto BHI
agar and incubation at 37 °C overnight.
An alternative method was also employed in which an over-
night culture of bacteria was diluted to 7 × 108 bacteria per ml,
washed twice in PBS and re-suspended in a solution of
FilmTracer™ FM® 1–43 Green Biofilm Cell Stain (Invitrogen,
UK) prepared according to manufacturer’s instructions for
20 min at RT. After washing thoroughly in PBS 100 µl of the
stained bacterial suspension was added to each coated well (as
above) the plates incubated at RT overnight. Plates were
washed 4 times with PBS to remove unattached bacteria and
residual fluorescence in the wells was measured using a plate-
reader (Infinite M200, Tecan, UK) operated by Magellan soft-
ware (excitation/emission: 472/580 nm).
The eﬀect of HB-PNIPAM-van on bacterial attachment
An overnight culture of S. aureus S-235 was diluted to 109 bac-
teria per ml, washed twice and resuspended in PBS. Then, in
fresh Eppendorf tubes, the bacterial suspension was mixed
with HB-PNIPAM-van (5 mg ml−1) or PBS at a final concen-
tration of 5 × 108 cells per ml. The tubes were incubated for
4 hours at 37 °C to encourage HB-PNIPAM-van and bacteria
binding. Afterwards, the PBS and HB-PNIPAM-van-S. aureus
mixtures or the PBS-bacteria controls were added to 96-well
microplates and incubated for 2 hours at 37 °C to initiate
attachment. Then, the plate was washed 3 times with PBS and
the samples stained with SYTO® 9 from LIVE/DEAD™
BacLight™ bacterial viability kit (Invitrogen, UK), (prepared
according to manufactures instructions). After washing to
remove any residual stain, fluorescence was measured using a
Tecan plate reader (excitation/emission: 488/520 nm).
Microscopic images were also acquired using the Zeiss
Axiovert 200 M inverted fluorescence microscope and the
AxioVision software.
The eﬀect of HB-PNIPAM-van on biofilm formation
Overnight cultures of S. aureus S-235 and S. aureus NCTC 8325-
4 were diluted and added to fresh BHI in a 24-well microplate
at a final concentration of 5 × 108 bacteria per ml.
HB-PNIPAM-van solution (500 µg ml−1 in PBS) was added to
wells while PBS alone was added to polymer-free wells as con-
trols. Biofilms were formed in at 37 °C for 24 hours with
gentle shaking (35 rpm), after which wells were washed with
PBS and stained with 0.1% (w/v) crystal violet solution for
20 min. The plate was washed thoroughly with water and
200 µl of 95% ethanol was added for 20 min to release the
stain from the biofilm bacteria. The absorbance of the
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resultant alcohol solution was measured at 595 nm using the
plate-reader mentioned previously.
The eﬀect of HB-PNIPAM-van on biofilm cell growth and
biofilm structure
To examine the eﬀects of HB-PNIPAM-van on growth of
attached cells and biofilm appearance, S. aureus S-235 biofilms
were formed as described above. HB-PNIPAM-van (5 mg ml−1)
in PBS was added to the microplate wells and incubation con-
tinued for a further 24 hours at 37 °C without shaking. Viable
counts from wells were obtained after washing, scraping, serial
dilution and plating on BHI agar as described above. The
metabolic activity of biofilm cells was assessed using the cell
proliferation kit II (XTT) (Roche). Briefly, to S. aureus S235 bio-
films 100 µl of XTT solution was added (prepared according to
manufacturer’s instructions), the plates were covered in foil
and incubated at 37 °C for 30 min. Following incubation, the
XTT solution was transferred into a fresh plate and absorbance
readings were recorded at 450 nm with a reference wavelength
of 690 nm.
The eﬀects of HB-PNIPAM-van on biofilm structure were
examined by fluorescence microscopy and scanning electron
microscopy (SEM). For fluorescence microscopy, 24 h S. aureus
S235 biofilms were grown in 96-well plates as above and
stained with 5 µg ml−1 of wheat germ agglutinin (WGA) (Texas
Red® – X conjugate, Thermo Fisher Scientific, UK) for
15 minutes at 37 °C. In parallel some biofilms were viewed by
phase contrast microscopy and this plus the fluorescence
images were collected using Zeiss Axiovert 200 M inverted fluo-
rescence microscope and AxioVision software. For scanning
electron microscopy S. aureus S235, 24 h biofilms were grown
in BHI on circular 13 mm diameter cover slips and treated
with PBS or HB-PNIPAM-van for 24 hours. Biofilms were then
fixed in 3% glutaraldehyde, 0.1 M sodium cacodylate (pH 7.2)
and stained, firstly with 0.15% Alcian blue and then with 2%
osmium tetroxide in 0.1 M sodium cacodylate (pH 7.2) accord-
ing to the method of Howlin et al. (2015).32 Finally, samples
were critically point dried and sputter coated with gold
(Edwards S150B). Images were acquired under full vacuum
using a Philips XL-20 scanning electron microscope.
Corneal infection model
Ex vivo corneas were obtained from wild brown rabbits
(Blackface Meat Company, Dumfries, Scotland) and their exci-
sion, decontamination and infection procedures were per-
formed according to the protocol described by Pinnock et al.,
(2016).28 After the development of infection, HB-PNIPAM-van
was made up in antibiotic-free Dulbecco’s modified eagle’s
medium (DMEM) to 5 mg ml−1 and 100 µl of this or PBS
(control) was added to the corneas and incubated for 4 hours at
37 °C. Afterwards, the corneas were homogenised and numbers
of bacteria were measured by viable counting as previously
described.28 Three corneas were used for each condition per
experiment and the experiment was repeated 3 times.
In experiments involving confocal microscopy, corneas were
infected with GFP-labelled S. aureus SH1000 according to the
procedures described above. After treatment with PBS or
HB-PNIPAM-van, corneas were washed twice with PBS and
attached to the bottom of a small petri dish (35 mm in dia-
meter) using a tissue adhesive glue (Vetbond™, 3 M Science).
Then, the petri dishes were filled with approximately 4 ml of
PBS and the corneas were analysed using a Zeiss LSM510 NLO
microscope, running AIM software and a Zeiss 63×/1.0 water
immersion lens. During preliminary studies, it was discovered
that the cornea exhibited some auto-fluorescence at the GFP
emission wavelength (Fig. 7), however this was of low intensity
and did not prevent imaging of the bacteria. The raw images
are shown in ESI, Fig. S4.† The confocal images were processed
using ImageJ where the brightness of both the auto-fluo-
rescence and bacterial fluorescence was artificially enhanced for
illustration purposes as this enabled visualisation of the bac-
teria on the corneal surface. There were 2 corneas for each con-
dition and the experiment was repeated twice.
Conclusions
HB-PNIPAM-van altered the biofilm structure on a surface,
inhibited bacterial cell attachment and reduced the bacterial
load in a simulated infection of the cornea. These findings
suggest that HB-PNIPAM-van oﬀers a new approach to limiting
the development of corneal infections and maybe a useful
adjunct to antimicrobial treatment.
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